Nutra Pharma Announces Laboratory Recertification and Manufacturing Updates
November 12, 2014 08:30 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Nov 12, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Retains BUYINS.NET to Surveil Short Sellers and Market-Makers
August 21, 2014 08:30 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Aug 21, 2014) - Nutra Pharma Corp (OTC: NPHC)
Approximately 547 Million Shares Shorted Since August 2009
Short...
Nutra Pharma Provides Nyloxin(R) Marketing Updates
August 19, 2014 08:00 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Aug 19, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces Nyloxin Television Commercial Rollout
June 25, 2014 10:09 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Jun 25, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces Completion of Commercials by MyNyloxin.com
June 25, 2014 09:23 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Jun 25, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces Contracts for Nyloxin Television Commercials
June 10, 2014 08:00 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Jun 10, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces Completion of Commercials by MyNyloxin.com
May 28, 2014 08:00 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - May 28, 2014) - Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma to Seek GSA Certification, Will Market Military Strength Nyloxin to Governmental Agencies and the DoD
April 22, 2014 08:30 ET
|
Nutra Pharma Corp.
CORAL SPRINGS, FL--(Marketwired - Apr 22, 2014) - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces New Telemarketing and Social Media Campaign Through MyNyloxin.com
April 03, 2014 08:30 ET
|
Nutra Pharma, Inc.
CORAL SPRINGS, FL--(Marketwired - Apr 3, 2014) - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...
Nutra Pharma Announces the First Shipments and Product Delivery to MyNyloxin.com Independent Entrepreneurs
January 07, 2014 09:33 ET
|
Nutra Pharma, Inc.
CORAL SPRINGS, FL--(Marketwired - Jan 7, 2014) - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis...